NO813804L - Substituerte pyrimidiner og fremgangsmaate for deres fremstilling - Google Patents

Substituerte pyrimidiner og fremgangsmaate for deres fremstilling

Info

Publication number: NO813804L
Authority: NO; Norway
Prior art keywords: procedures; preparation; substituted pyrimidines; pyrimidines; substituted
Prior art date: 1980-11-11

Application number

NO813804A

Other languages

English (en)

Other versions

NO160137C (no

NO160137B (no

Inventor

Susan Mary Daluge

Paul Marcel Skonezny

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-11-11

Filing date

1981-11-10

Publication date

1982-05-12

1981-11-10 Application filed by Wellcome Found filed Critical Wellcome Found

1982-05-12 Publication of NO813804L publication Critical patent/NO813804L/no

1988-12-05 Publication of NO160137B publication Critical patent/NO160137B/no

1989-03-15 Publication of NO160137C publication Critical patent/NO160137C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO813804A 1980-11-11 1981-11-10 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,4-diamino-5-(substituerte)-pyrimidiner. NO160137C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB8036135		1980-11-11

Publications (3)

Publication Number	Publication Date
NO813804L true NO813804L (no)	1982-05-12
NO160137B NO160137B (no)	1988-12-05
NO160137C NO160137C (no)	1989-03-15

Family

ID=10517217

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO813804A NO160137C (no)	1980-11-11	1981-11-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,4-diamino-5-(substituerte)-pyrimidiner.
NO1994029C NO1994029I1 (no)	1980-11-11	1994-12-29	Baquiloprim/ 2,4-diamino-5-(8-dimetylamino-7-metyl-5-kinolylmetyl)pyrimidin

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO1994029C NO1994029I1 (no)	1980-11-11	1994-12-29	Baquiloprim/ 2,4-diamino-5-(8-dimetylamino-7-metyl-5-kinolylmetyl)pyrimidin

Country Status (35)

Country	Link
US (4)	US4438267A (no)
EP (1)	EP0051879B1 (no)
JP (1)	JPS57114581A (no)
KR (1)	KR880001736B1 (no)
AR (1)	AR245447A1 (no)
AU (1)	AU549449B2 (no)
CA (1)	CA1186310A (no)
CS (1)	CS273153B2 (no)
CY (1)	CY1419A (no)
DD (1)	DD201896A5 (no)
DE (1)	DE3173752D1 (no)
DK (1)	DK172884B1 (no)
EG (1)	EG16107A (no)
ES (5)	ES8307759A1 (no)
FI (1)	FI76333C (no)
GB (1)	GB2087881B (no)
GR (1)	GR81317B (no)
HK (1)	HK23388A (no)
HU (1)	HU188762B (no)
IE (1)	IE52128B1 (no)
IL (1)	IL64256A (no)
IT (1)	IT1210589B (no)
MC (1)	MC1418A1 (no)
MY (1)	MY8600678A (no)
NO (2)	NO160137C (no)
NZ (1)	NZ198932A (no)
PH (2)	PH25053A (no)
PL (4)	PL139827B1 (no)
PT (1)	PT73960B (no)
RU (1)	RU1819264C (no)
SG (1)	SG62686G (no)
SU (4)	SU1424732A3 (no)
YU (5)	YU42444B (no)
ZA (1)	ZA817780B (no)
ZM (1)	ZM9481A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4438267A (en) *	1980-11-11	1984-03-20	Daluge Susan M	Monoheteroring compounds and their use
US4590271A (en) *	1982-05-01	1986-05-20	Burroughs Wellcome Co.	2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
ZA833067B (en) *	1982-05-01	1984-12-24	Wellcome Found	Antibacterial compounds
DK190983A (da) *	1982-05-01	1983-11-02	Wellcome Found	2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
US4587341A (en) *	1982-05-07	1986-05-06	Burroughs Wellcome Co.	2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) *	1983-04-14	1988-11-01	Hans Maag	Pyrimidine derivatives
GB8603962D0 (en) *	1986-02-18	1986-03-26	Wellcome Found	Chemical compositions
GB8603964D0 (en) *	1986-02-18	1986-03-26	Cooper Animal Health Ltd	Compositions
LU86703A1 (fr) *	1986-12-08	1988-07-14	Oreal	Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A0 (fi) *	1988-12-07	1989-12-05	Wellcome Found	Farmaceutiskt aktiva cns foereningar.
GB8903978D0 (en) *	1989-02-22	1989-04-05	Coopers Animal Health	Chemical compositions
GB9000241D0 (en) *	1990-01-05	1990-03-07	Coopers Animal Health	Pharmaceutical use
RU95113597A (ru) *	1992-12-02	1997-06-10	ФМК Корпорейшн (US)	Инсектицидная композиция, способы борьбы с насекомыми
US5707996A (en) *	1995-11-06	1998-01-13	Macleod Pharmaceuticals, Inc.	Pharmaceutical solution and methods for preparation thereof
DK0866791T3 (da) *	1995-12-04	2002-04-22	Arpida Ag	Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler
WO2002010156A1 (en) *	2000-07-29	2002-02-07	Arpida Ag	Benzofuran derivatives and their use as antibacterial agents
ATE343415T1 (de)	2001-06-29	2006-11-15	Ab Science	Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
WO2003002106A2 (en) *	2001-06-29	2003-01-09	Ab Science	Use of tyrosine kinase inhibitions for treating allergic diseases
US7727731B2 (en) *	2001-06-29	2010-06-01	Ab Science	Potent, selective and non toxic c-kit inhibitors
JP2004537537A (ja) *	2001-06-29	2004-12-16	アブサイエンス	炎症性疾患を治療するためのチロシンキナーゼ阻害剤の使用法
US20040242601A1 (en) *	2001-09-20	2004-12-02	Alain Moussy	Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
DE60225590T2 (de) *	2001-09-20	2008-09-25	Ab Science	C-kithemmer zur behandlung von bakteriellen infektionen
DE60227701D1 (de) *	2001-09-20	2008-08-28	Ab Science	Die verwendung von c-kithemmern zur förderung des haarwuchses
NZ545197A (en) *	2003-07-11	2009-06-26	Arpida Ag	Benzofuran derivatives and their use in the treatment of microbial infections
CA2596669A1 (en) *	2005-02-18	2006-08-24	Arpida Ag	Novel processes for the preparation of a 2h-chromene
CA2619898C (en) *	2005-09-01	2014-03-18	F. Hoffmann-La Roche Ag	Diaminopyrimidines as p2x3 and p2x2/3 modulators
WO2010003084A2 (en) *	2008-07-02	2010-01-07	Memory Pharmaceuticals Corporation	Phosphodiesterase 4 inhibitors
EP2440533B1 (en) *	2009-06-12	2015-09-23	Socpra-Sciences Et Génie S.E.C.	Guanine riboswitch binding compounds and their use as antibiotics
CN102649786B (zh) *	2011-02-28	2014-08-27	郑州福源动物药业有限公司	一种2，4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2，4-(1h，3h)嘧啶的制备方法
CN103755684B (zh) *	2014-02-10	2015-09-09	青岛蔚蓝生物股份有限公司	一种巴喹普林的制备方法
EP3981765A4 (en) *	2019-06-06	2023-05-31	Beijing Tide Pharmaceutical Co., Ltd.	P2X3 AND/OR P2X2/3 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
CN110818694B (zh) *	2019-11-18	2023-04-21	上海医药工业研究院有限公司	艾拉普林中间体及其应用
EP4320104A1 (en) *	2021-04-09	2024-02-14	The Trustees of The University of Pennsylvania	Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3049544A (en) *		1962-08-14		Method for the preparation of
DE1303727B (de)	1959-09-03	1976-02-05	Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London	Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) *	1969-03-06	1976-05-11	Burroughs Wellcome Co.	Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) *	1971-12-01	1973-05-30	Hoffmann La Roche	Nouvelles benzylpyrimidines
GB1468374A (en)	1974-03-06	1977-03-23	Wellcome Found	Process for preparing a pyrimidine derivative
US4039543A (en)	1974-12-24	1977-08-02	Hoffmann-La Roche Inc.	Benzylpyrimidines
GB1582245A (en) *	1976-06-09	1981-01-07	Wellcome Found	Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) *	1977-07-06	1979-01-18	Basf Ag	Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) *	1979-11-30	1981-03-24	Merck & Co., Inc.	Inhibitor of dihydrofolate reductase
US4438267A (en) *	1980-11-11	1984-03-20	Daluge Susan M	Monoheteroring compounds and their use

1981
- 1981-11-09 US US06/319,644 patent/US4438267A/en not_active Expired - Lifetime
- 1981-11-10 MC MC811560A patent/MC1418A1/xx unknown
- 1981-11-10 AU AU77334/81A patent/AU549449B2/en not_active Expired
- 1981-11-10 NO NO813804A patent/NO160137C/no not_active IP Right Cessation
- 1981-11-10 CS CS825781A patent/CS273153B2/cs unknown
- 1981-11-10 KR KR1019810004348A patent/KR880001736B1/ko active
- 1981-11-10 PL PL1981239278A patent/PL139827B1/pl unknown
- 1981-11-10 JP JP56180271A patent/JPS57114581A/ja active Granted
- 1981-11-10 SU SU813358051A patent/SU1424732A3/ru active
- 1981-11-10 DK DK198104966A patent/DK172884B1/da active Protection Beyond IP Right Term
- 1981-11-10 YU YU2663/81A patent/YU42444B/xx unknown
- 1981-11-10 PL PL1981233754A patent/PL139523B1/pl unknown
- 1981-11-10 ES ES506969A patent/ES8307759A1/es not_active Expired
- 1981-11-10 IE IE2631/81A patent/IE52128B1/en not_active IP Right Cessation
- 1981-11-10 PL PL1981239280A patent/PL139828B1/pl unknown
- 1981-11-10 EG EG653/81A patent/EG16107A/xx active
- 1981-11-10 IL IL64256A patent/IL64256A/xx not_active IP Right Cessation
- 1981-11-10 GR GR66482A patent/GR81317B/el unknown
- 1981-11-10 CA CA000389807A patent/CA1186310A/en not_active Expired
- 1981-11-10 PT PT73960A patent/PT73960B/pt unknown
- 1981-11-10 ZA ZA817780A patent/ZA817780B/xx unknown
- 1981-11-10 FI FI813546A patent/FI76333C/fi not_active IP Right Cessation
- 1981-11-10 DD DD81234745A patent/DD201896A5/de not_active IP Right Cessation
- 1981-11-10 IT IT8149676A patent/IT1210589B/it active
- 1981-11-10 GB GB8133833A patent/GB2087881B/en not_active Expired
- 1981-11-10 PL PL1981239279A patent/PL139427B1/pl unknown
- 1981-11-10 HU HU813359A patent/HU188762B/hu unknown
- 1981-11-10 NZ NZ198932A patent/NZ198932A/en unknown
- 1981-11-11 CY CY141981A patent/CY1419A/xx unknown
- 1981-11-11 ZM ZM94/81A patent/ZM9481A1/xx unknown
- 1981-11-11 EP EP81109631A patent/EP0051879B1/en not_active Expired
- 1981-11-11 DE DE8181109631T patent/DE3173752D1/de not_active Expired
1983
- 1983-01-27 SU SU833543245A patent/SU1318148A3/ru active
- 1983-01-31 SU SU833547444A patent/SU1306473A3/ru active
- 1983-04-02 ES ES521202A patent/ES8405378A1/es not_active Expired
- 1983-04-02 ES ES521201A patent/ES521201A0/es active Granted
- 1983-04-02 ES ES521204A patent/ES8405380A1/es not_active Expired
- 1983-04-02 ES ES521203A patent/ES8405379A1/es not_active Expired
- 1983-09-07 PH PH29503A patent/PH25053A/en unknown
- 1983-09-07 PH PH29502A patent/PH22654A/en unknown
- 1983-10-03 YU YU01981/83A patent/YU198183A/xx unknown
- 1983-10-03 YU YU1983/83A patent/YU43551B/xx unknown
- 1983-10-03 YU YU01982/83A patent/YU198283A/xx unknown
- 1983-10-31 US US06/546,850 patent/US4587342A/en not_active Expired - Lifetime
- 1983-12-30 US US06/567,248 patent/US4603136A/en not_active Expired - Lifetime
1986
- 1986-02-02 RU SU863552053A patent/RU1819264C/ru active
- 1986-03-12 US US06/839,463 patent/US4761475A/en not_active Expired - Lifetime
- 1986-07-17 SG SG626/86A patent/SG62686G/en unknown
- 1986-12-30 MY MY678/86A patent/MY8600678A/xx unknown
1987
- 1987-01-14 SU SU874028793A patent/SU1535379A3/ru active
1988
- 1988-03-30 HK HK233/88A patent/HK23388A/xx not_active IP Right Cessation
- 1988-06-17 AR AR88311165A patent/AR245447A1/es active
- 1988-07-26 YU YU144288A patent/YU46697B/sh unknown
1994
- 1994-12-29 NO NO1994029C patent/NO1994029I1/no unknown

Also Published As

Publication number	Publication date
DE3173752D1 (en)	1986-03-20
CS825781A2 (en)	1990-07-12
PL139427B1 (en)	1987-01-31
SG62686G (en)	1987-03-27
GB2087881A (en)	1982-06-03
US4761475A (en)	1988-08-02
EP0051879A3 (en)	1982-08-04
YU198183A (en)	1984-04-30
YU198383A (en)	1984-04-30
JPS57114581A (en)	1982-07-16
PL139523B1 (en)	1987-01-31
KR830007628A (ko)	1983-11-04
ES8405377A1 (es)	1984-06-01
FI813546L (fi)	1982-05-12
DK172884B1 (da)	1999-09-06
DD201896A5 (de)	1983-08-17
ZM9481A1 (en)	1983-11-21
YU198283A (en)	1984-04-30
EP0051879B1 (en)	1986-02-05
PL139828B1 (en)	1987-02-28
IE52128B1 (en)	1987-06-24
SU1424732A3 (ru)	1988-09-15
RU1819264C (ru)	1993-05-30
IL64256A (en)	1988-01-31
CS273153B2 (en)	1991-03-12
IL64256A0 (en)	1982-02-28
SU1318148A3 (ru)	1987-06-15
GB2087881B (en)	1985-05-15
IT8149676A0 (it)	1981-11-10
NO1994029I1 (no)	1994-12-29
CY1419A (en)	1988-04-22
PH25053A (en)	1991-01-28
HK23388A (en)	1988-04-08
YU46697B (sh)	1994-04-05
PT73960B (en)	1983-11-23
FI76333B (fi)	1988-06-30
YU144288A (en)	1990-04-30
NO160137C (no)	1989-03-15
ES521203A0 (es)	1984-06-01
PL233754A1 (en)	1983-08-01
PL139827B1 (en)	1987-02-28
MC1418A1 (fr)	1982-10-18
NO160137B (no)	1988-12-05
PH22654A (en)	1988-10-28
DK496681A (da)	1982-05-12
AU7733481A (en)	1982-05-20
CA1186310A (en)	1985-04-30
ES521204A0 (es)	1984-06-01
US4603136A (en)	1986-07-29
MY8600678A (en)	1986-12-31
US4587342A (en)	1986-05-06
PL239279A1 (en)	1983-08-01
AU549449B2 (en)	1986-01-30
ES506969A0 (es)	1983-07-01
PT73960A (en)	1981-12-01
EP0051879A2 (en)	1982-05-19
KR880001736B1 (ko)	1988-09-10
PL239278A1 (en)	1983-08-01
PL239280A1 (en)	1983-08-01
IE812631L (en)	1982-05-11
ES521201A0 (es)	1984-06-01
GR81317B (no)	1984-12-11
EG16107A (en)	1987-10-30
HU188762B (en)	1986-05-28
SU1306473A3 (ru)	1987-04-23
SU1535379A3 (ru)	1990-01-07
AR245447A1 (es)	1994-01-31
NZ198932A (en)	1985-05-31
US4438267A (en)	1984-03-20
ES8307759A1 (es)	1983-07-01
ES8405380A1 (es)	1984-06-01
YU43551B (en)	1989-08-31
YU42444B (en)	1988-08-31
IT1210589B (it)	1989-09-14
FI76333C (fi)	1988-10-10
ES8405379A1 (es)	1984-06-01
ZA817780B (en)	1983-06-29
ES521202A0 (es)	1984-06-01
YU266381A (en)	1984-04-30
JPH0474351B2 (no)	1992-11-26
ES8405378A1 (es)	1984-06-01

Publication	Publication Date	Title
NO813804L (no)	1982-05-12	Substituerte pyrimidiner og fremgangsmaate for deres fremstilling
NO813142L (no)	1982-03-17	N-arylbenzamid-derivater og fremgangsmaate for deres fremstilling.
NO814112L (no)	1982-06-07	1-sulfo-2-oksoazetidinderivater og fremgangsmaate for deres fremstilling
DK43981A (da)	1981-08-02	Kompositmaterialer og fremgangsmaade til deres fremstilling
NO801469L (no)	1980-11-19	Pyrimidinforbindelser og fremgangsmaate til deres fremstilling
DK446982A (da)	1983-04-10	Cyanosteroider og fremgangsmaade til deres fremstilling
DK457581A (da)	1982-04-18	4,5-polymethylen-4-isothiazolin-3-oner fremgangsmaade til deres fremstilling og deres anvendelse
NO810351L (no)	1981-08-05	G imidazolinderivater og fremgangsmaate til deres fremstillin
DK443683A (da)	1984-03-31	Triazolforbindelser og fremgangsmaader til deres fremstilling
DK290583D0 (da)	1983-06-23	Benzoylpiperazinestre og fremgangsmade til deres fremstilling
DK251281A (da)	1981-12-10	N6-adenosiner og fremgangsmaader til deres fremstilling
DK401882A (da)	1983-03-11	Cyclopentadienderivater og fremgangsmaader til deres fremstilling
NO821159L (no)	1982-10-08	2-piperazinopyrimidin og deres fremstilling.
DK58581A (da)	1981-08-13	Thiolestere deres fremstilling og anvendelse
DK165336C (da)	1993-03-29	Koncentrerede stofbloedgoerende midler og fremgangsmaader til deres fremstilling
NO811775L (no)	1981-11-30	Modifiserte krysotilasbest-fibre og fremgangsmaate til deres fremstilling.
DK556483D0 (da)	1983-12-02	Benzofuranylderivater og deres fremstilling
DK169481A (da)	1981-10-19	Kobberphthalocyaninpigmenter deres fremstilling og deres anvendelse
DK556381A (da)	1982-06-17	Pyrazolinforbindelser og deres fremstilling
NO812618L (no)	1982-05-18	Dekorative overflategjenstander og fremgangsmaate til deres fremstilling
NO821206L (no)	1982-10-14	Imidazolderivater og fremgangsmaate for deres fremstilling
NO824312L (no)	1983-06-27	4-cyano-2-azetidinoner og fremgangsmaate for deres fremstilling
NO791520L (no)	1979-11-12	Substituerte antitumorantracycliner og fremgangsmaate for deres fremstilling
DK20781A (da)	1981-07-18	Thioler og fremgangsmaader til deres fremstilling
DK433381A (da)	1982-04-02	Fremgangsmaade til fremstilling af 3-brom-4-fluorbenzylalkohol3-brom-4-fluorbenozesyre-derivater og fremgangsmaade til deres fremstilling

Legal Events

Date	Code	Title	Description
2002-01-02	MK1K	Patent expired	Free format text: EXPIRED IN NOVEMBER 2001